Timing Effects of Uracil‐induced Urolithiasis on Amplification of Second‐stage Promotion in Rat Bladder Carcinogenesis

The post‐initiation enhancing activities of the non‐genotoxic agent NaHCO(3) and the genotoxic agent N‐ethyl‐]N‐(4‐hydroxybuty])nitrosainine (EHBN) in combination with uracil‐induced urolithiasis were investigated in a rat bladder carcinogenesis model. Animals were treated with 0.05%N‐butyl‐N‐(4‐hydroxybutyl)nitrosamine (BBN) for 4 weeks, and then 3% uracil was given for 3 weeks in the early (weeks 4‐7), middle (weeks 8 11) or late (weeks 12–15) post‐initiation phase. In addition, administration of 3% NaHCO(3), 20 ppm EHBN or no chemical supplement was performed for the 13 weeks when the rats were not receiving BBN or uracil. NaHCO(3) in sequential combination with early and middle stages uracil treatment strongly enhanced tumorigenesis in the urinary bladder, while EHBN treatment amplified lesion development at the middle stage only of uracil treatment. DNA synthesis and associated epithelial surface alterations observed by scanning electron microscopy tended to be increased in the NaHCO(3) and EHBN groups without BBN initiation, independently of uracil treatment timing. The present results demonstrated that uracil‐induced urolithiasis during the middle post‐initiation phase is highly active in enhancing bladder tumor development under the influence of a promoter or carcinogen.